Income Statement

v3.8.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Income Statement [Abstract]        
Revenues $ 1,715,697 $ 873,549 $ 4,487,473 $ 2,135,445
Cost of revenues 447,967 422,722 1,294,388 953,562
Gross profit 1,267,730 450,827 3,193,085 1,181,883
Operating expenses:        
Personnel 269,795 111,870 574,481 351,322
Marketing and promotion 29,286 19,993 84,211 24,136
General and administrative 581,391 197,505 1,173,351 475,530
Depreciation and amortization 100,214 66,422 263,624 166,108
Total operating expenses 980,686 395,790 2,095,667 1,017,096
Operating income 287,044 55,037 1,097,418 164,787
Non-operating expenses:        
Interest expense, net 79,518 61,777 257,424 187,322
Equity compensation 284,640 284,640 5,154
Loss on debt conversions 463,855 482,133
Write-off of deferred revenue (226,940) (226,940)
Unrealized loss (gain) on trading securities 120 268
Total non-operating expenses 601,073 61,897 797,257 192,208
Net income (loss) (314,029) (6,860) 300,161 (27,421)
Net income (loss) attributable to non-controlling interests 78,421 53,962 177,852 182,768
Net income (loss) attributable to MariMed Inc. $ (392,450) $ (60,822) $ 122,309 $ (210,189)
Net income (loss) per share $ (0.002) $ (0.001) $ 0.001 $ (0.004)
Weighted average common shares outstanding 163,737,564 64,074,683 97,982,499 52,018,689

Source